Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Gene signatures for cancer prognosis

Gene signatures for cancer prognosis

US Patent 10954568 · Granted Mar 23, 2021

Estimated economic value: $32,192,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods and materials for assessing homologous recombination deficiency2025
Methods and materials for assessing homologous recombination deficiency2025
Adjusted multi-biomarker disease activity score for inflammatory disease assessm2025
Genes and gene signatures for diagnosis and treatment of melanoma2025
Methods and materials for assessing homologous recombination deficiency2025
Methods and materials for assessing homologous recombination deficiency2025
Method of using biomarkers and clinical variables for predicting chemotherapy be2024
Method of using biomarkers and clinical variables for predicting chemotherapy be2024
Genes and gene signatures for diagnosis and treatement of melanoma2023
Genes and gene signatures for diagnosis and treatment of melanoma2023
Method of using biomarkers and clinical variables for predicting chemotherapy be2022
Method of using biomarkers and clinical variables for predicting chemotherapy be2022